RxDoctor Payments Data

Quincy Scarborough, MD

Family Medicine · Middleburg, FLNPI 1003137852

Payments from drug & device makers

$13,932in general payments, 2019–2025

Across 207 payments — averaging $67.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$11K
  • AstraZeneca$448
  • Amarin Pharma, Inc.$277
  • Novo Nordisk$276
  • Merck$204
  • AbbVie$195
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$2,95799%
  • Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$13,932 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$91,071
Medicare patients
208
Services billed
1,134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$53,443
EliquisApixaban35$48,300
JanuviaSitagliptin Phosphate43$42,504
JardianceEmpagliflozin32$39,885
ProliaDenosumab11$19,801
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$17,945
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$11,777
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$10,041
SymbicortBudesonide/Formoterol Fumarate14$4,519
Atorvastatin Calcium282$3,021
Rosuvastatin Calcium209$2,432
Omeprazole134$2,408
Levothyroxine Sodium201$2,148
Gabapentin75$2,053
Famotidine69$1,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$276$53,44343 claims
PfizerEliquis$50$48,30035 claims
MerckJanuvia$204$42,50443 claims
Boehringer IngelheimJardiance$129$39,88532 claims
AmgenProlia$186$19,80111 claims
GSKAnoro Ellipta$11,048$17,94520 claims
AstraZenecaSymbicort$448$4,51914 claims
AbbVieSynthroid$195$1,35418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Middleburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →